ATTACHMENT
3
Premanufacture
Notice
(
PMN)
Form
and
Instructions
EPA
Form
7710­
15
[
For
electronic
copies
of
the
PMN
Form
and
Instructions,
see
http://
www.
epa.
gov/
opptintr/
newchems/
pmnforms.
htm
and
follow
the
appropriate
links.]
ATTACHMENT
4
Calculation
of
Hourly
Wage
Rates
(
Excerpt
from
Economic
Impact
Analysis)
1U.
S.
Department
of
Labor,
Bureau
of
Labor
Statistics.
Occupational
Compensation
Survey,
National
Summary
1996.

2Managerial
labor
is
assumed
to
be
composed
of
operational
labor,
including
engineers
or
chemists
at
the
plant
manager,
facility
research
manager,
or
higher
levels,
legal
managers,
and
financial
managers.

3Technical
labor
is
assumed
to
be
composed
of
operational
labor,
including
senior
engineers
or
chemists
equivalent
to
head
process
or
project
engineer,
and
financial
labor,
such
as
accountants.
It
is
assumed
that
operational
labor
is
used
at
a
five­
to­
one
ratio
with
financial
labor.

4The
methodology
used
for
the
CAIR
analysis
also
used
wage
information
for
chemists
in
estimating
the
managerial
and
technical
wage
rates.
The
current
methodology
does
not
include
chemists
in
estimating
the
composite
wage
rates
because
updated
information
on
wage
levels
for
chemists
was
not
available
from
BLS.
The
Engineer
salary
information
is
expected
to
be
similar
to
Chemist
salary
information.
In
addition,
BLS
data
for
Level
VI
attorneys
in
goods­
producing
industries
were
not
available,
so
wages
for
all
private
industry
level
VI
attorneys
were
used
instead.

5U.
S.
Department
of
Labor,
Bureau
of
Labor
Statistics.
Employment
Cost
Index
­
March
1998,
U.
S.
Department
of
Labor,
Washington,
D.
C.,
U.
S.
Department
of
Labor
News
Release
01­
236,
June
2001,
Table
6.

6U.
S.
Department
of
Labor,
Bureau
of
Labor
Statistics.
Employer
Costs
for
Employee
Compensation
­
March
2001,
www.
bls.
gov,
Table
11.
Calculation
of
Hourly
Wage
Rates
Wage
data
used
in
developing
the
basic
wage
rates
for
this
analysis
were
derived
from
1996
wage
information
published
by
the
Bureau
of
Labor
Statistics
(
BLS)
for
all
goods­
producing,
private
industries1.
The
managerial,
technical,
and
clerical
wage
rates
are
based
on
wage
information
for
four
BLS
occupation
categories:
engineers,
accountants,
attorneys,
and
secretaries.
As
shown
in
Table
A­
1,
the
managerial
and
technical
level
wage
rates
are
composites
of
the
BLS
wage
rates
for
several
occupation
categories
and
levels.
The
managerial
level
wage
rate
is
a
composite
of
the
wage
rates
of
Engineers
(
levels
VI­
VIII),
Accountants
(
levels
V­
VI),
and
Attorneys
(
levels
IV­
VI)
2.
The
technical
level
wage
is
a
composite
of
the
wage
rates
of
Engineers
(
levels
III­
VIII)
and
Accountants
(
levels
(
III­
VI)
3.
The
clerical
wage
rate
is
an
average
of
all
the
clerical
wage
levels
provided
by
BLS
(
i.
e.,
levels
I­
V).
The
weighting
factors
used
to
develop
the
managerial
and
technical
wage
rates
are
based
on
information
provided
by
the
chemical
industry
and
chemical
industry
trade
associations
on
the
typical
fraction
of
total
reporting
effort
that
is
accounted
for
by
each
specific
BLS
occupation
category.
4
The
1996
composite
annual
salary
estimates
were
adjusted
to
second­
quarter
2001dollars
using
the
Employment
Cost
Index
(
ECI)
for
three
categories
of
white­
collar
occupations
in
private
industries5.
The
2001
adjusted,
composite
salary
for
the
managerial,
technical,
and
clerical
labor
categories
was
then
multiplied
by
benefits
and
overhead
factors
to
estimate
a
2001
loaded,
annual
salary.
Detailed
benefits
data
for
white­
collar
occupations
in
private,
goods­
producing
industries
were
used
to
account
for
the
additional
cost
of
benefits
for
managerial,
technical,
and
clerical
labor6.
The
overhead
factor
of
17
percent
is
based
on
information
provided
by
the
chemical
industry
and
chemical
industry
trade
associations.
The
loaded
annual
salary
was
then
divided
by
2,080
hours
(
i.
e.,
the
average
number
of
hours
worked
per
year
by
a
full­
time
employee)
to
derive
the
loaded,
hourly
wage
rates
used
in
this
analysis
for
each
labor
category.
The
hourly
wage
rates
are
$
98.34
for
managerial
personnel,
$
72.89
for
technical
personnel
and
$
29.39
for
clerical
personnel,
all
in
2001
dollars.
TABLE
A­
1
LOADED
HOURLY
WAGE
RATES
BY
LABOR
CATEGORY
Labor
Category
Occupation
(
levels)
June
1996
Average
Salary
Weighting
Factor
1996
Composit
e
Salary*
ECI
Ratio
6/
96:

12/
01
2001
Adjusted
Salary
2001
Benefits
(%
Salary)
Overhead
(%
Salary)
2001
Loaded
Annual
Salary
2001
Loaded
Hourly
Rate
Managerial
Engineer
(
VI­
VIII)
$
104,971
10/
17
$
61,748
Attorney
(
IV­
VI)
$
116,255
5/
17
$
34,193
Accountant
(
V­
VI)
$
82,030
2/
17
$
9,651
Composite
$
105,592
1.23
$
129,878
40.5%
17.0%
$
204,558
$
98.34
Technical
Engineer
(
III­
VIII)
$
83,243
5/
6
$
69,369
Accountant
(
III­
VI)
$
65,780
1/
6
$
10,963
Composite
$
80,332
1.19
$
95,595
41.6%
17.0%
$
151,614
$
72.89
Clerical
Secretarial
(
I­
V)
$
31,502
1/
1
$
31,502
Composite
$
31,502
1.21
$
38,117
43.4%
17.0%
$
61,140
$
29.39
*
Composite
Salaries
are
determined
by
multiplying
average
salaries
by
the
weighting
factor
and
summing
across
occupations.

Sources:
U.
S.
Department
of
Labor,
Bureau
of
Labor
Statistics.
Occupational
Compensation
Survey,
National
Summary,
1996.
U.
S.
Department
of
Labor,
Bureau
of
Labor
Statistics.
Employment
Cost
Index
­
March
1998,
U.
S.
Department
of
Labor,
Washington,
D.
C.
U.
S.
Department
of
Labor
News
Release
01­
236,
June
2001,
Table
6.
ATTACHMENT
5
Selection
Criteria
­­
TSCA
Section
8(
a)
Rule
vs.
SNUR
SELECTION
CRITERIA:
These
criteria
serve
as
guidelines
and
not
as
rigid
standards
for
the
regulatory
selection
process.

SECTION
8(
a)
Rules
 
REQUIREMENTS,
TYPES
OF
DATA,
USES:

 
Statutory
prerequisites:
None
(
i.
e.,
no
required
risk
findings)
other
than
a
legitimate
Agency
need
for
such
data
"
as
the
Administrator
may
reasonably
require"
and
the
use
of
notice
and
comment
rulemaking
for
the
establishment
of
reporting
requirements.

­
Scope:
EPA
can
require
reporting
by
manufacturers,
importers,
and
processors
of
both
new
(
PMN)
and
existing
(
initial
Inventory)
chemical
substances.

­
Types
of
data:
EPA
may
use
section
8(
a)
rules
to
obtain
a
variety
of
health
and
environmental
data,
including
data
on
chemical
identity
and
structure,
uses,
volume
of
production/
importation/
processing,
byproducts,
health
and
environmental
effects,
exposure,
and
disposal.

­
Data
support
functions:
Section
8(
a)
rules
provide
background
exposure­
related
data
to
support
chemical
risk
assessment;
e.
g.,
data
support
for
section
4
testing
decisions,
voluntary
testing
decisions,
section
6
rulemaking,
section
9
referral
actions,
follow­
up
SNURs,
and
chemical
advisories.

­
Follow­
up
monitoring
function:
Section
8(
a)
rules
can
be
used
to
monitor
certain
chemical
activities
which
may
cause
significant
new
or
ongoing
exposures
to
the
subject
chemicals
(
i.
e.,
section
8(
a)
reporting
rules
can
be
triggered
by
the
commencement
of
certain
prescribed
chemical
activities
or
by
prescribed
changes
in
chemical
activities);
this
type
of
section
8(
a)
rule
ensures
that
EPA
will
receive
notification
and
information
concerning
the
chemical
activities
described
in
the
rule;
however,
the
Agency
can
only
take
follow­
up
action
through
lengthy
rulemaking
(
via
section
4,
5(
a)(
2),
or
6)
or
by
civil
action
in
cases
of
extreme
and
imminent
hazard
(
via
section
7).

CRITERIA
THAT
FAVOR
DEVELOPMENT
OF
A
SECTION
8(
a)
RULE
­
A
need
to
gather
data
for
chemical
risk
assessment,
with
no
perceived
need
for
immediate
shortterm
control
action:
The
basic
data
support
function
described
above
is
the
primary
function
of
section
8(
a)
rules.

­
Lesser
health
and
environmental
concerns:
If
EPA
intends
to
develop
a
follow­
up/
monitoring
rule
for
a
particular
chemical
substance,
the
Agency
would
favor
a
section
8(
a)
rule
when
the
level
of
OTS
concern
regarding
health
and
environmental
effects
of
the
chemical
is
not
sufficient
to
require
that
follow­
up
action
be
immediately
available
(
under
section
5(
e)
or
5(
f))
once
the
reporting
requirement
is
triggered
and
notification
is
received
by
EPA
(
e.
g.,
the
substances
is
an
eye
or
skin
irritant;
EPA
lacks
sufficient
data
on
health
and
environmental
effects
for
purposes
of
risk
assessment;
the
substance
may
cause
transient
neurotoxic
effects;
the
substances
has
moderate
acute
toxicity;
the
substance
may
persist
in
the
environment;
the
substance
may
cause
organ
damage
or
reduced
sperm
counts;
chronic
exposure
to
the
substance
may
result
in
health
effects
that
generally
are
reversible).
­
Activities
are
ongoing:
If
EPA
intends
to
develop
a
follow­
up/
monitoring
rule
for
a
particular
chemical
substance,
the
Agency
would
favor
a
section
8(
a)
rule
when
the
chemical
activities
in
question
are
ongoing
at
the
time
of
rulemaking
(
i.
e.,
currently
taking
place
or
recently
ceased
and
likely
to
resume)
or
are
likely
to
be
ongoing
when
the
rule
is
proposed.
By
definition,
a
SNUR
would
not
be
possible
under
such
circumstances.

­
A
need
for
long­
term
monitoring:
A
section
8(
a)
rule
is
favored
if
OTS
needs
to
monitor
industrywide
production
and
exposure
trends
on
a
long­
term
basis,
as
in
the
following
examples:

(
1)
The
rule
may
be
triggered
by
a
number
of
different
firms
over
time,
and
the
activity
eventually
may
be
considered
ongoing
(
thereby
preventing
a
SNUR);

(
2)
The
rule
may
be
triggered
a
number
of
times
by
the
same
firm,
and
the
activity
may
be
considered
ongoing;

(
3)
Potential
increases
in
exposure
are
expected
to
occur
gradually
over
time
and/
or
at
a
number
of
independent
sites,
making
it
necessary
for
the
Agency
to
gather,
aggregate,
and
analyze
exposure­
related
data
before
making
a
decision
about
the
potential
for
unreasonable
risk.

SECTION
5(
a)(
2)
SNURS
 
REQUIREMENTS,
TYPES
OF
DATA,
USES:

­
Statutory
prerequisites:
TSCA
does
not
require
a
risk
finding
for
SNURs.
The
only
statutory
requirements
are
(
1)
that
EPA
consider
"
all
relevant
factors"
(
including
the
four
exposure­
related
factors
in
section
5(
a)(
2))
before
designating
a
significant
new
use,
and
(
2)
that
the
use
not
be
ongoing
at
the
time
the
SNUR
is
promulgated
(
i.
e.,
not
currently
taking
place
or
recently
ceased
and
likely
to
resume).

­
Scope:
SNURs
may
be
applicable
to
manufacturers,
importers,
and
processors
of
both
new
and
existing
chemical
substances.

­
Types
of
data:
EPA
is
authorized
to
require
SNUR
notice
submitters
to
report
the
same
types
of
data
as
may
be
required
under
section
8(
a),
plus
certain
types
of
test
data
in
certain
limited
cases
(
note
that
health
and
environmental
data
must
already
be
in
the
"
possession
or
control"
of
the
person
submitting
the
notice
(
other
health
and
environmental
data
which
are
known
to
or
reasonably
ascertainable
by
the
person
submitting
the
notice,
which
need
only
be
described));
EPA
generally
requires
SNUR
respondents
to
complete
the
PMN
reporting
form.

­
Follow­
up
monitoring
function:
SNURs
can
serve
largely
the
same
monitoring/
notification/
information
function
as
section
8(
a)
rules,
with
three
important
differences:

(
1)
A
significant
new
use
must
be
an
activity
that
is
not
ongoing
at
the
time
the
SNUR
is
promulgated;
(
2)
A
SNUR
respondent
cannot
commence
the
significant
new
use
while
EPA
is
evaluating
the
data
in
the
SNUR
notice;
(
3)
TSCA
authorizes
EPA
to
take
immediate
follow­
up
control
action
under
either
section
5(
e)
(
the
Agency
lacks
data
but
determines
that
the
activity
may
present
an
unreasonable
risk)
or
section
5(
f)
(
the
activity
will
present
an
unreasonable
risk
and
section
6
action
is
necessary).

CRITERIA
THAT
FAVOR
DEVELOPMENT
OF
A
SECTION
5(
a)(
2)
SNUR:

 
Greater
health
and
environmental
concerns:
If
the
potential
health
and
environmental
hazards
posed
by
a
chemical
substance
are
of
sufficient
concern
to
OTS
that
the
Agency
wants
to
be
able
to
do
the
following:

(
1)
Monitor
potential
exposure/
risk
which
may
be
caused
by
non­
ongoing
activities
involving
the
subject
chemical;

(
2)
Prevent
these
activities
from
occurring
until
OTS
has
completed
its
assessment
of
the
activities
and
has
determined
the
potential
for
release
and
exposure;

(
3)
Take
immediately
effective
control
action
(
if
necessary)
via
section
5(
e)
or
5(
f)
to
prevent
the
activities
from
occurring
(
at
least
on
an
interim
basis)
after
the
completion
of
Agency
review
(
e.
g.,
the
substance
is
a
possible
or
probably
human
carcinogen;
the
substance
may
cause
human
teratogenic
or
reproductive
effects;
the
substance
has
high
acute
toxicity;
the
substance
tends
to
bioaccumulate
in
living
tissue
and
is
slow
to
biodegrade;
chronic
exposure
to
the
substance
may
result
in
health
effects
that
generally
are
irreversible).

 
Likely
that
small
businesses
engage
in
the
activities:
Section
8(
a)
exempts
small
manufacturers,
importers,
and
processors
(
as
defined
by
EPA)
from
reporting
requirements
under
that
section.
The
Agency
therefore
may
not
receive
adequate
data
from
a
section
8(
a)
rule
in
some
cases
if
a
substantial
number
of
the
firms
subject
to
the
rule
qualify
as
"
small."
If
EPA
can
determine
prior
to
rulemaking
that
there
is
a
likelihood
that
respondents
will
be
small
firms,
the
Agency
may
wish
to
ensure
that
it
will
have
access
to
information
from
these
key
potential
respondents
by
developing
a
SNUR
for
datagathering
purposes.

OTHER
CRITERIA
THAT
MAY
AFFECT
THE
REGULATORY
SELECTION
PROCESS
(
examined
in
every
case):

­
Federal
regulatory
action
and
state
statutory/
regulatory
action
involving
the
subject
chemical:
Relevant
to
the
current
need
for
OTS
regulatory
action,
the
likelihood
of
ongoing
or
future
activities,
and
past
experiences
involving
the
subject
chemical.

­
Know
past
and
present
activities
and
projected
future
activities
involving
the
subject
chemical
(
including
the
size
of
the
firms
involved,
the
volume
of
production/
importation/
processing,
potential
releases
and
exposures,
etc.):
If
available,
this
information
is
a
relevant
supplement
to
all
of
the
section
8(
a)/
SNUR
criteria
listed
above.

­
Concerns
and
objective
of
EPA
and
the
technical
staff
responsible
for
the
subject
chemical:
ECAD
regulatory
staff
relies
heavily
on
continuing
input
from
management
(
with
regard
to
long­
term
regulatory
objectives
for
the
subject
chemical)
and
technical
staff
(
with
regard
to
health
and
environmental
concerns
and
short­
term
regulatory
objectives).
ATTACHMENT
6
Selected
SNUR
Case
History
Abstracts
HEXACHLORONORBORNADIENE
(
CAS
#
2432­
99­
7)

°
also
known
as
HEX­
BCH.

II.
TOXICITY
°
Extremely
persistent
compound
with
a
great
tendency
to
bioaccumulate.
°
Slow
biodegradation.
°
Very
toxic
to
fish.
°
Possible
analogue
to
known
carcinogens.

II.
REFERRING
OFFICE'S
CONCERNS/
NEEDS
°
Monitor:
its
manufacture,
importation,
and
processing;
intended
end
uses,
and
potential
worker
exposure
and
environmental
releases.
°
Once
production
levels
reach
a
certain
point,
EPA
will
reconsider
its
decision
not
to
text
HEX­
BCH.

III.
USES
A.
Past
and
Ongoing
°
Commercial
batch
manufacture
and
processing.
°
Intermediate
in
the
production
of
isodrin
which
is
an
intermediate
in
the
production
of
endrin
(
both
pesticides).

B.
Small
Business
°
Capable
of
production
by
a
small
firm.

IV.
REGULATORY
BACKGROUND
°
Listed
on
the
Preliminary
Assessment
Information
Rule.
(
One­
time
reporting
only).
°
Listed
on
the
section
8(
d)
model
health
and
safety
data
reporting
rule
(
40
CFR
Part
716).
°
Local
limit
on
its
discharge
in
a
public
treatment
system.
Limit
based
on
plant's
treatment
capacity
and
not
on
human
health
or
environmental
risk.
V.
RECOMMENDATION/
RATIONALE:
Section
8(
a)
rule
for
ongoing
uses
and
significant
new
use
rule
for
non­
ongoing
uses.

°
Well
documented
high
toxicity
concern.
°
Small
businesses
potential.
°
Satisfies
referring
office's
needs.
°
No
federal
regulation
exists
to
provide
a
governmental
entity
with
an
opportunity
to:
evaluate
potential
human
and
environmental
exposures
to
HEX­
BCH
from
its
manufacture,
importation,
processing,
and
intended
end
use;
and
to
protect
human
beings
and
the
environment
from
potentially
adverse
exposures
before
they
occur.
METHYL
N­
BUTYL
KETONE
(
CASE
#
591­
78­
6)

°
also
known
as
MBK.

VII.
TOXICITY
°
Causes
central
and
peripheral
neuropathy
in
humans.
Nerve
damage
is
irreversible
at
concentrations
as
low
as
50
ppm.
°
Absorbed
readily
through
the
skin.
°
Eye
and
skin
irritant.
°
Limited
evidence
suggests
testicular
atrophy.

II.
REFERRING
OFFICE'S
CONCERNS/
NEEDS
°
Monitor:
its
resumption
of
commercial
manufacture,
importation,
and
processing;
intended
end
uses,
and
potential
worker
and
consumer
exposure.

III.
USES
A.
Past
°
Commercial
manufacture,
importation
and
processing.
°
Solvent
in
lacquers,
sealers,
varnish
removers,
oils,
fats,
and
waxes.
(
i.
e.,
consumer
products).

B.
Ongoing
°
Importation
for
toxicological
research
and
development.

C.
Small
Business
°
Capable
of
production
by
a
small
firm.

IV.
REGULATORY
BACKGROUND
°
Occupational
Safety
and
Health
Administration
standard
(
8
hour
Time
Weighted
Average
(
TWA)
100
ppm).
°
American
Conference
of
Governmental
Industrial
Hygienists
TWA
5
ppm.
No
binding
effect.
°
National
Institute
of
Occupational
Safety
and
Health
TWA
5
ppm.
No
binding
effect.

V.
RECOMMENDATION/
RATIONALE:
Significant
new
use
rule.

°
Well
documented
high
toxicity
concern.
°
Small
businesses
potential.
°
Satisfies
referring
office's
needs.
°
No
federal
regulation
exists
to
provide
a
governmental
entity
with
an
opportunity
to:
evaluate
potential
human
and
environmental
exposures
to
MBK
from
its
manufacture,
importation,
processing,
and
intended
end
use;
and
to
protect
human
beings
and
the
environment
from
potentially
adverse
exposures
before
they
occur.
URETHANE
(
CASE
#
51­
79­
6)

°
Urethane
is
a
name
commonly
but
improperly
applied
to
high
molecular
weight
polyurethanes
used
as
foams,
elastomers,
and
coatings.
These
products
are
not
made
from
the
urethane,
and
do
not
generate
urethane
upon
decomposition.

X.
TOXICITY
°
Urethane
is
well
established
as
a
carcinogen.
Malignant
tumors
have
occurred
in
many
species
of
animals
following
the
administration
of
urethane
by
the
oral,
inhalation,
topical,
subcutaneous,
and
intraperitoneal
routes.
Urethane
is
also
a
transplacental
carcinogen
that
readily
traverses
the
placenta
and
affects
the
fetus.
°
Toxic
fumes
when
heated;
liver
toxin;
bone
marrow
depressant.

II.
REFERRING
OFFICE'S
CONCERNS/
NEEDS
°
Monitor:
its
resumption
of
manufacture,
importation,
and
processing;
intended
end
uses,
and
potential
worker
and
consumer
exposure.

III.
USES
A.
Past
°
Commercial
manufacture,
importation
and
processing.
°
Intermediate
in
the
production
of
N­
hydroxymethyl
derivatives,
which
are
useful
as
cross­
linking
agents
for
imparting
wash­
and­
wear
properties
to
fabrics.
°
Human
medicine:
sclerosing
agent
for
varicose
veins
and
hemorrhoids,
antineoplastic
agent,
hypnotic,
treatment
of
chronic
leukemia,
and
multiple
myeloma.
°
Pharmaceutical
intermediate.

B.
Ongoing
°
Toxicological
research.

C.
Small
Business
°
Capable
of
production
by
a
small
firm.

IV.
REGULATORY
BACKGROUND
°
Banned
by
the
Food
and
Drug
Administration
as
an
active
and
inactive
ingredient
in
drugs.
FDA
also
prohibited
the
use
of
a
food
preservative
that
produces
urethane
when
it
is
used
tin
acidic
beverages.
°
Designated
by
EPA
as
a
Toxic
Hazardous
Waste
#
238.
°
Listed
as
a
Hazardous
material
under
the
Hazardous
Materials
Transportation
Act.
V.
RECOMMENDATION/
RATIONALE:
Significant
new
use
rule.

°
Well
documented
high
toxicity
concern.
°
Small
businesses
potential.
°
Satisfies
referring
office's
needs.
°
No
federal
regulation
exists
to
provide
a
governmental
entity
with
an
opportunity
to:
evaluate
potential
human
and
environmental
exposures
from
urethane's
manufacture,
importation,
processing,
and
intended
end
use;
and
to
protect
human
beings
and
the
environment
from
potentially
adverse
exposures
before
they
occur.

The
consequences
of
not
collecting
this
information
is
to
allow,
without
EPA
review,
human
and
environmental
exposures
to
toxic
chemical
substances.
PENTABROMOETHYLBENZENE
(
CASE
#
85­
22­
3)

°
also
known
as
PEB.

X.
TOXICITY
°
Carcinogenicity
observed
in
other
structurally
related
compounds
having
a
polyhalogenated
aromatic
moiety.
°
Persistent
compound
with
a
great
tendency
to
bioaccumulate.
°
Slow
biodegradation.

II.
REFERRING
OFFICE'S
CONCERNS/
NEEDS
°
Monitor:
its
resumption
of
commercial
manufacture,
importation,
and
processing;
intended
end
uses,
and
potential
worker
exposure
and
environmental
release.
°
If
production
is
to
be
reinstated,
EPA
will
reconsider
its
decision
not
to
test
HEXBCH

III.
USES
A.
Past
and
Ongoing
°
Has
been
used
in
the
past
as
an
additive­
type
flame
retardant.
°
No
known
ongoing
uses.

B.
Small
Business
°
Capable
of
production
by
a
small
firm.

V.
REGULATORY
BACKGROUND
°
The
Interagency
Testing
Committee
designed
PEB
for
priority
consideration
in
its
15th
report.
°
Listed
on
the
section
8(
d)
model
health
and
safety
data
reporting
rule
(
40
CFR
Part
716).
°
Listed
on
the
Preliminary
Assessment
Information
Rule.
(
40
CFR
Part
712).
°
Proposed,
pursuant
to
section
4(
a)(
1)(
A)
findings,
that
chemical
fate
and
environmental
effects
testing
be
performed.
°
Proposed
Test
Rule
withdrawn
due
to
termination
of
all
known
manufacture
and
processing
operations.
V.
RECOMMENDATION/
RATIONALE:
Significant
new
use
rule.

°
Structurally
analogous
to
substances
of
carcinogenic
concern.
°
Small
businesses
potential.
°
Satisfies
referring
office's
needs.
°
No
federal
regulation
exists
to
provide
a
governmental
entity
with
an
opportunity
to:
evaluate
potential
human
and
environmental
exposures
to
PEB
from
its
manufacture,
importation,
processing,
and
intended
end
use;
and
to
protect
human
beings
and
the
environment
from
potentially
adverse
exposures
before
they
occur.
